Actinium Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly) Analysis

Actinium Pharmaceuticals, Inc. (ATNM)

1.51 +0.06 (+4.14%) USD | NYAM | Dec 12, 16:00

1.51 0.00 (0.00%) After-Hours: 16:50

View EPS Diluted from Other Gain/Loss (Quarterly) for ATNM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Arcus Biosciences, Inc.	--
Apyx Medical Corp.	--
AbbVie, Inc.	--
Karyopharm Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--